CHF-6563

N/A

Report date: 2024/01/10 15:11:40
NME

Base Information

Drug NameCHF-6563
Drug Alias NameCHF-6563
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor agonists
TargetsMu opioid receptor
Therapy Area/IndicationsNeonatal Abstinence Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChiesi Farmaceutici SPA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChiesi Farmaceutici SPA
Active IndicationsN/A
Inactive IndicationsNeonatal Abstinence Syndrome

Other Information

ATC CodeN/A
Related LinksN/A